Gelstat Overview

  • Status
  • Public

  • Employees
  • 11

  • Stock Symbol
  • GSAC

Stock Symbol
  • Investments
  • 2

Gelstat General Information


GelStat Corp is a consumer healthcare company operating in the US. It is engaged in the development and marketing of over-the-counter (OTC) and other non-prescription consumer healthcare products. The company's lead product is Gelstat Migraine, which is a patented OTC homeopathic drug for use as a first-line, acute treatment for migraine and migraine-like headaches. The Gelstat Migraine is developed to provide acute relief from headache pain as well as other symptoms associated with a migraine. The other products of the company include CHEWS 2 LOSE, which is a diet aide in the form of an all-natural appetite suppressant gum; All Natural Speed which targets specific quick-fix energy user groups; and GelStat Sleep, which provides relief from sleep disorders and their associated symptoms.

Contact Information

Formerly Known As
Gelstat Corporation
Ownership Status
Publicly Held
Financing Status
Primary Industry
Stock Exchange
Primary Office
  • 3557 SW Corporate Parkway
  • Palm City, FL 34990
  • United States
+1 (772) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Gelstat Stock Performance

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS

Gelstat Financials Summary

In Thousands,
TTM 31-Dec-2008 FY 2008 31-Dec-2008 FY 2007 31-Dec-2007 FY 2006 31-Dec-2006
EV 2,185
Revenue 23 23 18 234
EBITDA (417) (417) (1,039) (1,761)
Net Income (463) (463) (1,083) (1,818)
Total Assets 47 47 103 170
Total Debt 459 459 472 472
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Gelstat Patents

Gelstat Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2003284322-A1 Dietary supplement comprising parthenolide Abandoned 05-Nov-2002 000000000
EP-1558270-A1 Dietary supplement comprising parthenolide Withdrawn 05-Nov-2002 000000000
US-20040086579-A1 Orally administering the oral dosage comprising parthenolide; retaining at least a portion of the administered oral dosage in the oral cavity for a time sufficient to allow absorption of parthenolide by oral mucosal tissues Abandoned 05-Nov-2002 000000000
CA-2503644-A1 Dietary supplement comprising parthenolide Abandoned 05-Nov-2002 000000000
US-20060013904-A1 Treatment method comprising administering feverfew to oral mucosal tissues in solid or semi-solid form Abandoned 05-Nov-2002 A61K36/82
To view Gelstat’s complete patent history, request access »

Gelstat Executive Team (2)

Name Title Board Seat Contact Info
Laurence Gershman Chief Executive Officer & Chairman
Gerald Kieft Chief Financial Officer & Board Member
To view Gelstat’s complete executive team members history, request access »

Gelstat Board Members (2)

Name Representing Role Since
000000 00000 Self Chief Financial Officer & Board Member 000 0000
00000000 00000000 Gelstat Chief Executive Officer & Chairman 000 0000
To view Gelstat’s complete board members history, request access »

Gelstat Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Gelstat Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 000000 08-Jul-2014 0000000000 00.00 Drug Discovery 00000000
CBD Life Sciences 23-Oct-2013 Merger/Acquisition Food Products 000000 00
To view Gelstat’s complete acquisitions history, request access »